Cargando…
Chemokine-Like Receptor 1 Deficiency Does Not Affect the Development of Insulin Resistance and Nonalcoholic Fatty Liver Disease in Mice
The adipokine chemerin and its receptor, chemokine-like receptor 1 (Cmklr1), are associated with insulin resistance and nonalcoholic fatty liver disease (NAFLD), which covers a broad spectrum of liver diseases, ranging from simple steatosis to nonalcoholic steatohepatitis (NASH). It is possible that...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004559/ https://www.ncbi.nlm.nih.gov/pubmed/24781986 http://dx.doi.org/10.1371/journal.pone.0096345 |
_version_ | 1782313991186415616 |
---|---|
author | Gruben, Nanda Aparicio Vergara, Marcela Kloosterhuis, Niels J. van der Molen, Henk Stoelwinder, Stefan Youssef, Sameh de Bruin, Alain Delsing, Dianne J. Kuivenhoven, Jan Albert van de Sluis, Bart Hofker, Marten H. Koonen, Debby P. Y. |
author_facet | Gruben, Nanda Aparicio Vergara, Marcela Kloosterhuis, Niels J. van der Molen, Henk Stoelwinder, Stefan Youssef, Sameh de Bruin, Alain Delsing, Dianne J. Kuivenhoven, Jan Albert van de Sluis, Bart Hofker, Marten H. Koonen, Debby P. Y. |
author_sort | Gruben, Nanda |
collection | PubMed |
description | The adipokine chemerin and its receptor, chemokine-like receptor 1 (Cmklr1), are associated with insulin resistance and nonalcoholic fatty liver disease (NAFLD), which covers a broad spectrum of liver diseases, ranging from simple steatosis to nonalcoholic steatohepatitis (NASH). It is possible that chemerin and/or Cmklr1 exert their effects on these disorders through inflammation, but so far the data have been controversial. To gain further insight into this matter, we studied the effect of whole-body Cmklr1 deficiency on insulin resistance and NAFLD. In view of the primary role of macrophages in hepatic inflammation, we also transplanted bone marrow from Cmklr1 knock-out (Cmklr1(-/-)) mice and wild type (WT) mice into low-density lipoprotein receptor knock-out (Ldlr(-/-)) mice, a mouse model for NASH. All mice were fed a high fat, high cholesterol diet containing 21% fat from milk butter and 0.2% cholesterol for 12 weeks. Insulin resistance was assessed by an oral glucose tolerance test, an insulin tolerance test, and by measurement of plasma glucose and insulin levels. Liver pathology was determined by measuring hepatic inflammation, fibrosis, lipid accumulation and the NAFLD activity score (NAS). Whole-body Cmklr1 deficiency did not affect body weight gain or food intake. In addition, we observed no differences between WT and Cmklr1(-/-) mice for hepatic inflammatory and fibrotic gene expression, immune cell infiltration, lipid accumulation or NAS. In line with this, we detected no differences in insulin resistance. In concordance with whole-body Cmklr1 deficiency, the absence of Cmklr1 in bone marrow-derived cells in Ldlr(-/-) mice did not affect their insulin resistance or liver pathology. Our results indicate that Cmklr1 is not involved in the pathogenesis of insulin resistance or NAFLD. Thus, we recommend that the associations reported between Cmklr1 and insulin resistance or NAFLD should be interpreted with caution. |
format | Online Article Text |
id | pubmed-4004559 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-40045592014-05-02 Chemokine-Like Receptor 1 Deficiency Does Not Affect the Development of Insulin Resistance and Nonalcoholic Fatty Liver Disease in Mice Gruben, Nanda Aparicio Vergara, Marcela Kloosterhuis, Niels J. van der Molen, Henk Stoelwinder, Stefan Youssef, Sameh de Bruin, Alain Delsing, Dianne J. Kuivenhoven, Jan Albert van de Sluis, Bart Hofker, Marten H. Koonen, Debby P. Y. PLoS One Research Article The adipokine chemerin and its receptor, chemokine-like receptor 1 (Cmklr1), are associated with insulin resistance and nonalcoholic fatty liver disease (NAFLD), which covers a broad spectrum of liver diseases, ranging from simple steatosis to nonalcoholic steatohepatitis (NASH). It is possible that chemerin and/or Cmklr1 exert their effects on these disorders through inflammation, but so far the data have been controversial. To gain further insight into this matter, we studied the effect of whole-body Cmklr1 deficiency on insulin resistance and NAFLD. In view of the primary role of macrophages in hepatic inflammation, we also transplanted bone marrow from Cmklr1 knock-out (Cmklr1(-/-)) mice and wild type (WT) mice into low-density lipoprotein receptor knock-out (Ldlr(-/-)) mice, a mouse model for NASH. All mice were fed a high fat, high cholesterol diet containing 21% fat from milk butter and 0.2% cholesterol for 12 weeks. Insulin resistance was assessed by an oral glucose tolerance test, an insulin tolerance test, and by measurement of plasma glucose and insulin levels. Liver pathology was determined by measuring hepatic inflammation, fibrosis, lipid accumulation and the NAFLD activity score (NAS). Whole-body Cmklr1 deficiency did not affect body weight gain or food intake. In addition, we observed no differences between WT and Cmklr1(-/-) mice for hepatic inflammatory and fibrotic gene expression, immune cell infiltration, lipid accumulation or NAS. In line with this, we detected no differences in insulin resistance. In concordance with whole-body Cmklr1 deficiency, the absence of Cmklr1 in bone marrow-derived cells in Ldlr(-/-) mice did not affect their insulin resistance or liver pathology. Our results indicate that Cmklr1 is not involved in the pathogenesis of insulin resistance or NAFLD. Thus, we recommend that the associations reported between Cmklr1 and insulin resistance or NAFLD should be interpreted with caution. Public Library of Science 2014-04-29 /pmc/articles/PMC4004559/ /pubmed/24781986 http://dx.doi.org/10.1371/journal.pone.0096345 Text en © 2014 Gruben et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Gruben, Nanda Aparicio Vergara, Marcela Kloosterhuis, Niels J. van der Molen, Henk Stoelwinder, Stefan Youssef, Sameh de Bruin, Alain Delsing, Dianne J. Kuivenhoven, Jan Albert van de Sluis, Bart Hofker, Marten H. Koonen, Debby P. Y. Chemokine-Like Receptor 1 Deficiency Does Not Affect the Development of Insulin Resistance and Nonalcoholic Fatty Liver Disease in Mice |
title | Chemokine-Like Receptor 1 Deficiency Does Not Affect the Development of Insulin Resistance and Nonalcoholic Fatty Liver Disease in Mice |
title_full | Chemokine-Like Receptor 1 Deficiency Does Not Affect the Development of Insulin Resistance and Nonalcoholic Fatty Liver Disease in Mice |
title_fullStr | Chemokine-Like Receptor 1 Deficiency Does Not Affect the Development of Insulin Resistance and Nonalcoholic Fatty Liver Disease in Mice |
title_full_unstemmed | Chemokine-Like Receptor 1 Deficiency Does Not Affect the Development of Insulin Resistance and Nonalcoholic Fatty Liver Disease in Mice |
title_short | Chemokine-Like Receptor 1 Deficiency Does Not Affect the Development of Insulin Resistance and Nonalcoholic Fatty Liver Disease in Mice |
title_sort | chemokine-like receptor 1 deficiency does not affect the development of insulin resistance and nonalcoholic fatty liver disease in mice |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004559/ https://www.ncbi.nlm.nih.gov/pubmed/24781986 http://dx.doi.org/10.1371/journal.pone.0096345 |
work_keys_str_mv | AT grubennanda chemokinelikereceptor1deficiencydoesnotaffectthedevelopmentofinsulinresistanceandnonalcoholicfattyliverdiseaseinmice AT apariciovergaramarcela chemokinelikereceptor1deficiencydoesnotaffectthedevelopmentofinsulinresistanceandnonalcoholicfattyliverdiseaseinmice AT kloosterhuisnielsj chemokinelikereceptor1deficiencydoesnotaffectthedevelopmentofinsulinresistanceandnonalcoholicfattyliverdiseaseinmice AT vandermolenhenk chemokinelikereceptor1deficiencydoesnotaffectthedevelopmentofinsulinresistanceandnonalcoholicfattyliverdiseaseinmice AT stoelwinderstefan chemokinelikereceptor1deficiencydoesnotaffectthedevelopmentofinsulinresistanceandnonalcoholicfattyliverdiseaseinmice AT youssefsameh chemokinelikereceptor1deficiencydoesnotaffectthedevelopmentofinsulinresistanceandnonalcoholicfattyliverdiseaseinmice AT debruinalain chemokinelikereceptor1deficiencydoesnotaffectthedevelopmentofinsulinresistanceandnonalcoholicfattyliverdiseaseinmice AT delsingdiannej chemokinelikereceptor1deficiencydoesnotaffectthedevelopmentofinsulinresistanceandnonalcoholicfattyliverdiseaseinmice AT kuivenhovenjanalbert chemokinelikereceptor1deficiencydoesnotaffectthedevelopmentofinsulinresistanceandnonalcoholicfattyliverdiseaseinmice AT vandesluisbart chemokinelikereceptor1deficiencydoesnotaffectthedevelopmentofinsulinresistanceandnonalcoholicfattyliverdiseaseinmice AT hofkermartenh chemokinelikereceptor1deficiencydoesnotaffectthedevelopmentofinsulinresistanceandnonalcoholicfattyliverdiseaseinmice AT koonendebbypy chemokinelikereceptor1deficiencydoesnotaffectthedevelopmentofinsulinresistanceandnonalcoholicfattyliverdiseaseinmice |